Jorge Rey

Jorge Rey practices at Sylvester Comprehensive Cancer Center in Miami, Florida, part of University of Miami.

Jorge Rey's NPI, 1982855466, was assigned on October 2, 2008. Jorge Rey graduated from Universidad del Valle Health Sciences in 1997. Jorge Rey holds Florida license ME109208.

Jorge Rey's primary practice is Sylvester Comprehensive Cancer Center, at 1475 Nw 12th Ave, Miami, FL 33136.

Jorge Rey's primary practice is Sylvester Comprehensive Cancer Center in Miami, Florida, part of University of Miami. The medical group on file is University of Miami Health System. Dmand AI also links Jorge Rey to 1 more group practice or clinic, named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Jorge Rey practices, 2 sites in all. Vendor and product names are available with a free account.

Vascular surgery is Jorge Rey's primary specialty in the NPI Registry, under taxonomy code 2086S0129X. Jorge Rey is board certified in vascular surgery by the American Board of Surgery. Dmand AI has Jorge Rey's licenses on file in 2 states: Florida and New York.

Dmand AI lists amputation, aortic atherosclerois, arterial blot clot /embolism, carotid revascularization, chronic skin ulcer, circulatory problems in extremities, deep vein thrombosis (DVT) and heart device and aorta surgery among the conditions Jorge Rey treats.

CMS data shows 444 Medicare services from Jorge Rey across 13 procedure codes in 2024, for 310 Medicare patients. Medicare paid $35,737 for them.

CMS counts 310 Medicare patients who saw Jorge Rey in 2024. The largest group is 75 to 84, with 125 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 45% are also on Medicaid. Their average risk score is 2.45, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Jorge Rey's median patient age at 73, with 50% women.

In 2024, Jorge Rey wrote 261 Medicare Part D claims for 88 patients. 70% of them were for generic drugs. CMS names the drug for 145 of them, across 4 drugs with 11 or more claims each, at $41,022 in total drug cost.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 88 out of 100 for Jorge Rey for performance year 2024, reported as part of a group. Jorge Rey accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Jorge Rey as offering telehealth.

Leg revascularization (restoring blood flow): 1 to 10 procedures (CMS shows small counts as a range)

Spinal fusion: 1 to 10 procedures (CMS shows small counts as a range)

Varicose vein removal: 1 to 10 procedures (CMS shows small counts as a range)

Dmand AI links 33 papers to Jorge Rey, published from 2013 to 2025. 2021 was the busiest year, with 4. The most frequent topics are Endovascular Procedures, Blood Vessel Prosthesis Implantation and Aortic Aneurysm, Abdominal. Jorge Rey has published most often in Ann Vasc Surg. Jorge Rey's most frequent co-authors are Arash Bornak, MD, Naixin Kang, MD and Stefan Carl Kenel-Pierre, MD.

CMS Open Payments shows 43 general payments to Jorge Rey from 13 drug and device companies from 2024 to 2025. Travel and lodging make up the largest share, 64% of the total. Medtronic, Inc. paid the most, $5,780.

Dmand AI lists 2 awards for Jorge Rey, most recently CMS Stage 1 EHR in 2014.

Jorge Rey graduated from Universidad del Valle Health Sciences in 1997. Jorge Rey is a member of ACS and SVS.

Jorge Rey is in network with 12 carriers, including Elevance, Aetna and Excellus BlueCross BlueShield. PPO plans come from the most carriers, 8. Check the plan with the practice before a visit.